| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
St. Jude Children's Research Hospital, Memphis, Tennessee 38101
Twenty children with rhabdomyosarcoma were treated in a coordinated program utilizing surgery, radiotherapy, and combination chemotherapy. Therapy was determined by the stage of disease at which treatment was initiated. Of the 20 patients, 15 developed complete regression of tumor; 4 patients developed partial response. Of the 9 patients who are alive, 7 have been tumor free for 2 to 39 months. Concurrent radiotherapy and prolonged, intensive, combination chemotherapy are well tolerated following surgery for rhabdomyosarcoma. The coordinated use of these modalities offers prospects of curing more children who have this tumor.
1 Supported by Cancer Research Center Grant CA 08480 and Clincal Cancer Training Grant CA 08151 from the National Cancer Institute, and by ALSAC. Presented in part at the 62nd Annual Meeting of the American Association for Cancer Research, Chicago, Ill., April 8, 1971.
2 To whom reprint requests should be addressed at St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, Tenn. 38101.
Received 9/30/71. Accepted 12/ 8/71.
This article has been cited by other articles:
![]() |
W. M. Crist, J. R. Anderson, J. L. Meza, C. Fryer, R. B. Raney, F. B. Ruymann, J. Breneman, S. J. Qualman, E. Wiener, M. Wharam, et al. Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease J. Clin. Oncol., June 15, 2001; 19(12): 3091 - 3102. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |